arrow
R

Roberto Nitsch

AstraZeneca
H指数:22
被引数:2,521

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCR

通过清除时间dPCR揭示人类干细胞和T细胞中设计核酸酶的切割和修复周期

2025-11-030
OAAI
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery
2020-09-2935
OAAI
HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases
2020-07-1522
OAAI
HACE1 deficiency leads to structural and functional neurodevelopmental defects
2019-06-0131
OAAI
Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype

在人源化小鼠模型中使用CRISPR/Cas9进行治疗性基因组编辑可改善 α1-抗胰蛋白酶缺乏症表型

2018-03-0157
OAAI
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate (vol 15, pg 1481, 2016)
2016-09-0116
OAAI
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
2016-05-0142
OAAI
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response
2014-02-1087
OAAI
A dual role for autophagy in a murine model of lung cancer

自噬在小鼠肺癌模型中的双重作用

2014-01-20390
OA